Last reviewed · How we verify
NCT06080828
Transdermal Neuromodulation for Management of Chronic Pelvic Pain in Women
NA trial testing Percutaneous Posterior Tibial Nerve Stimulation in Pelvic Pain Syndrome in 35 participants. Completed in 30 November 2023.
30 October 2023
Quick facts
| Lead sponsor | Kafrelsheikh University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 35 |
| Start date | 1 August 2023 |
| Primary completion | 30 October 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Percutaneous Posterior Tibial Nerve Stimulation
- Placebo Percutaneous Posterior Tibial Nerve Stimulation
- Home instructions
Conditions studied
- Pelvic Pain Syndrome — all drugs for Pelvic Pain Syndrome →
Sponsor
Kafrelsheikh University
Who can join
Adults 20 to 30, female only, with Pelvic Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: Chronic pelvic pain (CPP) significantly impacts the quality of life in women. This study investigated the effects of transdermal neuromodulation in females with CPP. Trial Design: Parallel, randomized, single-blind, controlled trial The aim of the study will be to examine the effect of posterior tibial nerve stimulation on women with idiopathic chronic pelvic pain syndrome. Methods: Thirty females with chronic pelvic pain will be randomly allocated 1:1 to receive either transdermal neuromodulation of the posterior tibial nerve (intervention group) or advice to control posture (control group) for 4 weeks at the Outpatient Physical Therapy Clinic at Kafrelsheikh University in Egypt. The primary outcome was pain intensity measured by visual analog scale (VAS). Secondary outcomes were serum cortisol level and quality of life (QOL) score. Assessments will be done at baseline and after 4 weeks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06080828
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pelvic Pain Syndrome
Currently open trials in the same condition.
- NCT07472842 — Study on the Outcomes of Patients Treated in Gynecological Emergency Departments for Pelvic Endometriosis or Suspected P · NA · recruiting
- NCT06124664 — Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities · recruiting
- NCT06102733 — Chronic Pelvic Pain in Females and Males · recruiting
Other Kafrelsheikh University trials
Trials by the same sponsor.
- NCT07585396 — Inositol in Letrozol Resistant PCOS Women · Phase 2, PHASE3 · not yet recruiting
- NCT07433920 — L-PRF Versus Sticky Bone Grafting of the Jumping Gap in AI-assisted Computer-Guided Socket Shield Immediate Implantation · NA · recruiting
- NCT07368348 — Evaluation of Internal Nasal Splint-Supported Free Graft Versus Nasoseptal Flap for Endoscopic Skull Base Repair in Cere · NA · recruiting
- NCT07348094 — Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin · NA · recruiting
- NCT07359144 — Pilates Exercises on Nonspecific Low Back Pain in Postnatal Women · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06080828 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kafrelsheikh University
- Last refreshed: 25 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06080828.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing